Application 021005
- Type
- NDA
- Sponsor
- FOUGERA PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SOLARAZE | DICLOFENAC SODIUM | GEL;TOPICAL | 3% | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021005-001 | SOLARAZE | DICLOFENAC SODIUM | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021005-001 | SOLARAZE | 3% | GEL / TOPICAL | RLD | 2000-10-16 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021005-001 | SOLARAZE | 3% | GEL / TOPICAL | RLD | 2000-10-16 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021005-001 | SOLARAZE | 3% | GEL / TOPICAL | RLD | 2000-10-16 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021005-001 | SOLARAZE | 3% | GEL / TOPICAL | AB | RLD, RS | 2000-10-16 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N021005-001 | SOLARAZE | 3% | GEL / TOPICAL | RLD | 2000-10-16 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021005-001 | SOLARAZE | 3% | GEL / TOPICAL | RLD | 2000-10-16 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021005-001 | SOLARAZE | 3% | GEL / TOPICAL | RLD | 2000-10-16 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021005-001 | SOLARAZE | 3% | GEL / TOPICAL | AB | RLD, RS | 2000-10-16 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N021005-001 | SOLARAZE | 3% | GEL / TOPICAL | AB | RLD, RS | 2000-10-16 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N021005-001 | SOLARAZE | 3% | GEL / TOPICAL | AB | RLD, RS | 2000-10-16 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N021005-001 | SOLARAZE | 3% | GEL / TOPICAL | AB | RLD, RS | 2000-10-16 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N021005-001 | SOLARAZE | 3% | GEL / TOPICAL | AB | RLD, RS | 2000-10-16 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N021005-001 | SOLARAZE | 3% | GEL / TOPICAL | AB | RLD, RS | 2000-10-16 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N021005-001 | SOLARAZE | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GEL / TOPICAL | RLD | 2000-10-16 | f41ea6bd6efb… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021005-001 | AB | 1 | 74a2ff9319b5… |
| 2021-03-12 10:30 UTC | 2021-03 | N021005-001 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N021005-001 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N021005-001 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N021005-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N021005-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N021005-001 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MEMBERS MARK ARTHRITIS PAIN RELIEVER | DICLOFENAC SODIUM | Sam's West Inc | d339aaa2-ae7e-4a79-b687-cf0a3106fad0 | 2025-07-16 | Warnings | DICLOFENAC SODIUM |
| Diclofenac Sodium Delayed Release | DICLOFENAC SODIUM | Golden State Medical Supply, Inc. | 39e67a90-df3e-ad30-e063-6394a90a7a82 | 2025-07-14 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| Diclofenac Sodium | DICLOFENAC SODIUM | Sun Pharmaceutical Industries, Inc. | f9a0c654-5f77-430f-b921-295eb776cbcd | 2025-07-10 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| Diclofenac Sodium | DICLOFENAC SODIUM | Advagen Pharma Ltd | ac2b4060-a5da-4ddf-a734-2ff58a1f98c9 | 2025-07-03 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| Diclofenac sodium | DICLOFENAC SODIUM | Sun Pharmaceutical Industries, Inc. | aa1e1ed3-0444-4bf5-a0ee-5d21a7fca391 | 2025-07-02 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| Arthritis Pain Reliever | DICLOFENAC SODIUM | Chain Drug Consortium, LLC | 8879a2ed-6c66-4489-8adc-9f160241cc7d | 2025-06-25 | Warnings | DICLOFENAC SODIUM |
| kirkland signature arthritis pain relief | DICLOFENAC SODIUM | Costco Wholesale Company | c30353da-acd6-474f-8a64-abd078bf4f85 | 2025-06-11 | Warnings | DICLOFENAC SODIUM |
| members mark arthritis pain reliever | DICLOFENAC SODIUM | Sam's West Inc | 44533b5b-73ce-4853-9eda-506426cb9b82 | 2025-06-09 | Warnings | DICLOFENAC SODIUM |
| Diclofenac Sodium Delayed Release | DICLOFENAC SODIUM | Carlsbad Technology, Inc. | 363764a0-e0a8-3e3f-e063-6294a90ad672 | 2025-06-01 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| Diclofenac Sodium Delayed Release | DICLOFENAC SODIUM | Carlsbad Technology, Inc. | 40879600-ba6c-43a8-aa5d-d0d41503d593 | 2025-05-28 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | Aurobindo Pharma Limited | 3487033c-7c62-4034-8718-73a7c49b26a0 | 2025-05-09 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| Diclofenac Sodium | DICLOFENAC SODIUM | PD-Rx Pharmaceuticals, Inc. | 87d5a720-f154-4c4b-b2d4-0ae58455dda0 | 2025-05-05 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| Diclofenac sodium | DICLOFENAC SODIUM | BluePoint Laboratories | 896e3f7d-88e6-4563-b879-a2757d19fd62 | 2025-05-02 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | Advagen Pharma Ltd | 72419a68-4c9d-44e0-9b43-922440e2c8d7 | 2025-04-30 | Warnings, Adverse reactions | DICLOFENAC SODIUM |
| up and up arthritis pain reliever | DICLOFENAC SODIUM | Target Corporation | 0b7ae58c-cdaf-4343-a199-7a90bf901eb5 | 2025-04-27 | Warnings | DICLOFENAC SODIUM |
| Diclofenac Sodium | DICLOFENAC SODIUM | NorthStar Rx LLC | c7431496-c0ef-403a-9716-92d942709b3d | 2025-04-25 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| Diclofenac Sodium | DICLOFENAC SODIUM | GERI-CARE PHARMACEUTICAL CORP | fc08e58c-6323-e667-e053-6394a90ab754 | 2025-04-21 | Warnings | DICLOFENAC SODIUM |
| Diclofenac Sodium | DICLOFENAC SODIUM | RedPharm Drug, Inc. | 4ecb7bdc-4a5e-7444-e054-00144ff88e88 | 2025-04-09 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| Diclofenac Sodium | DICLOFENAC SODIUM | Bryant Ranch Prepack | 487fa223-f4d9-4ab1-a5af-fb0d93f2bd0e | 2025-03-28 | Boxed warning, Warnings, Adverse reactions | DICLOFENAC SODIUM |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | INNOVUS PHARMACEUTICALS, INC. | ad9d2c28-21bc-4f81-9c90-cce6a96d976a | 2025-03-25 | Warnings | DICLOFENAC SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0168-0803 | DICLOFENAC SODIUM | diclofenac sodium | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | NDA AUTHORIZED GENERIC | Current |
| 0168-0844 | DICLOFENAC SODIUM | diclofenac sodium | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | NDA AUTHORIZED GENERIC | Current |
| 10337-803 | Solaraze | diclofenac sodium | PharmaDerm a division of Fougera Pharmaceuticals Inc. | NDA | Current |
| 10337-844 | Solaraze | diclofenac sodium | PharmaDerm a division of Fougera Pharmaceuticals Inc. | NDA | Current |
| 10337-844 | Solaraze | diclofenac sodium | PharmaDerm a division of Fougera Pharmaceuticals Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 80373 | SUPPL | 2024-11-25 |
| 80302 | SUPPL | 2024-11-22 |
| 72637 | SUPPL | 2022-11-17 |
| 72636 | SUPPL | 2022-11-17 |
| 72618 | SUPPL | 2022-11-15 |
| 70713 | SUPPL | 2022-04-06 |
| 70712 | SUPPL | 2022-04-06 |
| 70706 | SUPPL | 2022-04-06 |
| 67381 | SUPPL | 2021-05-03 |
| 67266 | SUPPL | 2021-04-30 |
| 23215 | SUPPL | 2016-05-18 |
| 14147 | SUPPL | 2016-05-11 |
| 4018 | SUPPL | 2016-05-11 |
| 26461 | SUPPL | 2011-12-14 |
| 14146 | SUPPL | 2011-12-14 |
| 26460 | SUPPL | 2007-06-07 |
| 4017 | SUPPL | 2004-07-28 |
| 26459 | SUPPL | 2004-03-24 |
| 21349 | ORIG | 2003-07-08 |
| 35862 | SUPPL | 2003-05-29 |
| 26458 | SUPPL | 2003-05-29 |
| 14145 | ORIG | 2000-10-16 |
| 4016 | ORIG | 2000-10-16 |